Baxter Healthcare SA
An insider at 1 company in coverage, as reported on Form 4. SEC CIK 1582211. Latest Form 4 filed Aug 2, 2013.
Roles
As stated on the filings: the relationship to the company and any officer title.
| Company | Role | Transactions | First | Latest |
|---|---|---|---|---|
| Traws Pharma, Inc.TRAW | 10% owner | 3 | 2013-07-30 | 2013-07-30 |
Transactions: 3
Every transaction reported, newest first, including grants, exercises and derivative securities. Purchases and sales (codes P and S) are open-market trades. The reported price is as stated on the form.
What these mean: insiders, Form 4, transaction codes, Rule 10b5-1 plans.
| Date | Company | Transaction | Shares | Reported price | Value | Filing |
|---|---|---|---|---|---|---|
| 2013-07-30 | Traws Pharma, Inc.10% owner | ConversionSeries J Convertible Preferred Stock | 3,030,303 | $0.00 | $0 | Form 4 |
| 2013-07-30 | Traws Pharma, Inc.10% owner | Purchase | 330,000 | $15.00 | $5.0m | Form 4 |
| 2013-07-30 | Traws Pharma, Inc.10% owner | Conversion | 2,273,295 | not reported | not reported | Form 4 |
Source: SEC EDGAR, Forms 4. Last ingested by Listed: Oct 30, 2026, 02:58 ET. Listed shows no prices and gives no investment advice.